Damon Runyon Researchers

Meet Our Scientists
Corina E. Antal, PhD

Dr. Antal aims to develop ways to increase the efficacy of pancreatic cancer chemotherapy. The reason for pancreatic cancer drug resistance is the presence of a dense, supportive tissue surrounding the cancer cells. She is using multiple high-throughput approaches to identify and target key genes within this tissue in order to reduce its supportive role. This work will aid in developing therapies to increase the delivery of the chemotherapeutic drugs to the tumor, allowing immune cells to infiltrate the tumor and kill cancer cells.

Project title: "Stromal reprogramming as a therapeutic approach in pancreatic cancer"
Institution: The Salk Institute for Biological Studies
Named Award: Robert Black Fellow
Award Program: Fellow
Sponsor(s) / Mentor(s): Ronald M. Evans, PhD
Cancer Type: Pancreatic
Research Area: Drug Discovery